-
-
D341652-25mgA selective thromboxane A2 receptor antagonist which exerts protective effects on brain infarction in vitro, heart cell injury due to hypoxia and hypoglycemia and lowers serum CPK activity in vitro.
-
D341652-5mgA selective thromboxane A2 receptor antagonist which exerts protective effects on brain infarction in vitro, heart cell injury due to hypoxia and hypoglycemia and lowers serum CPK activity in vitro.
-
-
-
D105965-100gProduct IntroductionDaminozide is a commonly used plant growth regulator, which acts by inhibiting 2-oxoglutarate-dependent dioxygenase activity in the gibberellin biosynthesis pathway.ApplicationDaminozide may be used as a reference standard for
-
D105965-25gProduct IntroductionDaminozide is a commonly used plant growth regulator, which acts by inhibiting 2-oxoglutarate-dependent dioxygenase activity in the gibberellin biosynthesis pathway.ApplicationDaminozide may be used as a reference standard for
-
D105965-500gProduct IntroductionDaminozide is a commonly used plant growth regulator, which acts by inhibiting 2-oxoglutarate-dependent dioxygenase activity in the gibberellin biosynthesis pathway.ApplicationDaminozide may be used as a reference standard for
-
-
D412556-25mgInformationDanicopan (ACH-4471) Danicopan (ACH-4471, ACH-0144471, ACH-CFDIS, ALXN 2040) is a potent, selective and orally active inhibitor of factor D with Kd of 0.54 nM for human Factor D. Danicopan inhibits alternative pathway of complement (APC)
-
D412556-5mgInformationDanicopan (ACH-4471) Danicopan (ACH-4471, ACH-0144471, ACH-CFDIS, ALXN 2040) is a potent, selective and orally active inhibitor of factor D with Kd of 0.54 nM for human Factor D. Danicopan inhibits alternative pathway of complement (APC)
-
D178502-10mgProduct description:Danirixin is a selective, and reversible CXCR2 antagonist, with IC50 of 12.5 nM for CXCL8.